Words of wisdom. Re: Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial. Escudier B, Pluzanska A, Koralewski P, et al., for the AVOREN Trial investigators. uri icon

Overview

publication date

  • October 1, 2008

Identity

Scopus Document Identifier

  • 58249093739

Digital Object Identifier (DOI)

  • 10.1016/j.eururo.2008.07.026

PubMed ID

  • 18953756

Additional Document Info

volume

  • 54

issue

  • 4